A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men

NCT06631430 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3810477
DRUG: BI 3810477
DRUG: Placebo

Sponsor

Boehringer Ingelheim